Bacteria causing typhoid fever are becoming increasingly resistant to some of the most important antibiotics for human health, according to a study published in The Lancet Microbe journal. The largest genome analysis of Salmonella ...
Jun 21, 2022
0
482
A new study published in The Lancet estimates that RSV-attributable acute lower respiratory infection was responsible for more than 100,000 deaths in children under five across the globe in 2019. The study is the first to ...
May 20, 2022
0
72
A review of adverse events following vaccination against COVID-19 with mRNA vaccines in the U.S. confirms that most side effects were mild and decreased substantially after one day. The new study, published in The Lancet ...
Mar 7, 2022
0
272
Six different COVID-19 boosters are safe and provoke strong immune responses in people who have previously received a two-dose course of ChAdOx1-nCov19 (Oxford–AstraZeneca [ChAd]) or BNT162b2 (Pfizer-BioNTech [BNT]), according ...
Dec 3, 2021
0
350
People who have received two vaccine doses against COVID-19 have a lower, but still appreciable, risk of becoming infected with the delta variant compared with unvaccinated people. Vaccinated people clear the infection more ...
Oct 28, 2021
0
312
An expert review by an international group of scientists, including some at the WHO and FDA, concludes that, even for the delta variant, vaccine efficacy against severe COVID is so high that booster doses for the general ...
Sep 13, 2021
0
516
People infected with the SARS-CoV-2 delta variant have approximately double the risk of hospitalization compared with those infected with the alpha variant, a study of more than 40,000 cases from England between 29 March ...
Aug 28, 2021
1
880
A new study published in The Lancet Infectious Diseases journal has found that the risk of delayed acute complications after non-hospitalized SARS-CoV-2 infection is low, but persistent symptoms in this group could lead to ...
May 11, 2021
0
47
Two new studies, published in The Lancet Infectious Diseases and The Lancet Public Health, found no evidence that people with the B.1.1.7. variant experience worse symptoms or a heightened risk of developing long COVID compared ...
Apr 13, 2021
0
94
A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus (BBIBP-CorV) is safe and elicits an antibody response, findings from a small early-phase randomised clinical trial published today in The ...
Oct 16, 2020
1
524
